5 quarters tracked · Beat rate 100% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.77 | $6.03 | +4.5% | Beat |
| Q1 2026 | 2026-03-31 | $5.29 | $5.44 | +2.8% | Beat |
| Q4 2025 | 2025-12-31 | $6.51 | $6.57 | +0.9% | Beat |
| Q3 2025 | 2025-09-30 | $5.55 | $5.79 | +4.4% | Beat |
| Q2 2025 | 2025-06-30 | $5.28 | $5.36 | +1.6% | Beat |
Earnings Beat Rate
Thermo Fisher Scientific has beaten analyst EPS estimates in 5 of 5 tracked quarters (100% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →